Marisa DiMarzio, Radhika Madhavan, Suresh Joel, Ileana Hancu, Eric Fiveland, Julia Prusik, Michael Gillogly, Tanweer Rashid, Jacquelyn MacDonell, Jeffrey Ashe, Ilknur Telkes, Paul Feustel, Michael D Staudt, Damian S Shin, Jennifer Durphy, Roy Hwang, Era Hanspal, Julie G Pilitsis
BACKGROUND: Deep brain stimulation (DBS) is a well-accepted treatment of Parkinson's disease (PD). Motor phenotypes include tremor-dominant (TD), akinesia-rigidity (AR), and postural instability gait disorder (PIGD). The mechanism of action in how DBS modulates motor symptom relief remains unknown. OBJECTIVE: Blood oxygen level-dependent (BOLD) functional magnetic resonance imaging (fMRI) was used to determine whether the functional activity varies in response to DBS depending on PD phenotypes...
June 2020: Neuromodulation: Journal of the International Neuromodulation Society